Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Delivery System In XAFTY Improves Effectiveness Against Dengue

Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth?
The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to mosquito propagation, deficient measures for vector control, and population inflation in areas at high risk. Dengue treatments lessen the number of dengue cases by facilitating prompt medical intervention, mitigating intense symptoms, stopping complications, and containing the spread of the disease through improved patient results and boosting public health awareness. For example, the Centers for Disease Control and Prevention, a government agency based in the US, reported in 2023 that over 4.6 million dengue fever cases in the Americas, alongside roughly 4,000 mortalities. This was an increase of 13% when compared with the same timeframe in 2022 and a notable escalation from prior years. Therefore, the escalating dengue case count is fueling the expansion of the market for dengue treatments.

Get Your Dengue Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/dengue-treatment-global-market-report

What is the future CAGR of the dengue treatment market, and how will it impact industry expansion?
The market size of dengue treatment has witnessed a swift expansion in the last few years. The projection suggests an increase from $2.10 billion in 2024 to $2.35 billion in 2025, with a compound annual growth rate (CAGR) of 12.0%. The surge during the preceding period is primarily due to advancements in diagnostic instruments, initiatives by governments and non-governmental organizations, the establishment of epidemiological surveillance systems, hefty investment in research and development, and significant community education measures.

The size of the treatment market for dengue is anticipated to experience swift expansion in the coming years, reaching a value of $3.64 billion in 2029, with a compound annual growth rate (CAGR) of 11.6%. The growth projected for this period can be credited to factors such as universal vaccine development, increased accessibility to vaccines, collaborations between public and private sectors, the rise of telemedicine, and improvements in the policy framework. The forecast period also points to significant trends such as the development of next-gen dengue vaccines, drug discovery through AI, sophisticated contact tracing mechanisms, 3D-printed vaccines, and the utilization of CRISPR for virus targeting.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20745&type=smp

What are the most significant trends transforming the dengue treatment market today?
Large corporations active in the dengue therapy industry are concentrating their efforts on creating solutions such as extensive antiviral drugs to better treat the disease, lessen its severity, and simultaneously tackle several forms of the dengue virus. A broad-spectrum antiviral medication implies a drug that is efficient in combating a variety of viruses, as opposed to one that only targets a specific virus type. As an example, Hyundai Pharmaceutical Co. Ltd., a pharmaceutical producer from South Korea, introduced a revolutionary antiviral with wide range named XAFTY in September 2024. This antiviral is designed to combat various viral infections, including COVID-19 and dengue fever. Its attributes include an innovative formulation enhancing the absorption and effectiveness of niclosamide, safety and efficacy backed up by clinical trials, versatility against a range of RNA viruses, swift response, and potential fast deployment to areas experiencing public health emergencies.

Which key market segments comprise the dengue treatment market and drive its revenue growth?
The dengue treatment market covered in this report is segmented -

1) By Type: Vaccines, Acetaminophen
2) By Route Of Administration: Parenteral, Oral
3) By Drug Class: Nsaids, Antibiotics, Corticosteroids
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospital, Specialty Clinics, Home Healthcare

Subsegments:
1) By Vaccines: Live Attenuated Vaccines, Recombinant Vaccines, Inactivated Vaccines
2) By Acetaminophen: Oral Acetaminophen, Intravenous Acetaminophen

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20745

What regions are at the forefront of dengue treatment market expansion?
Asia-Pacific was the largest region in the dengue treatment in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the dengue treatment market?
Major companies operating in the dengue treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., Sanofi S.A., Abbott Laboratories, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Incorporated, Emergent BioSolutions Inc., Bharat Biotech International Limited, Inovio Pharmaceuticals Inc., Gennova Biopharmaceuticals Ltd., ABIVAX S.A., Cadila Healthcare Limited, Biological E. Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20745&type=smp

What Is Covered In The Dengue Treatment Global Market Report?

•Market Size Forecast: Examine the dengue treatment market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the dengue treatment market for a structured understanding.
•Key Players Overview: Analyze major players in the dengue treatment market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the dengue treatment market.
•Segment Contributions: Evaluate how different segments drive overall growth in the dengue treatment market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the dengue treatment market.
•Industry Challenges: Identify potential risks and obstacles affecting the dengue treatment market.
•Competitive Landscape: Review strategic developments in the dengue treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.